1. A Case of Granulocyte-Colony Stimulating Factor-Producing Hepatocellular Carcinoma Confirmed by Immunohistochemistry
- Author
-
Kiyoshi Matsubayashi, Satoru Joshita, Kiyoshi Furuta, Kiyoshi Kitano, Eiji Tanaka, Hideharu Miyabayashi, Kaname Yoshizawa, Shoichiro Koike, Koh Nakazawa, and Atsushi Kamijo
- Subjects
Male ,Pathology ,medicine.medical_specialty ,Carcinoma, Hepatocellular ,Case Report ,Bone Neoplasms ,Biology ,Fatal Outcome ,Precursor cell ,Granulocyte Colony-Stimulating Factor ,medicine ,Carcinoma ,Humans ,Leukocytosis ,Oncology & Hematology ,Receptor ,Aged ,Liver Neoplasms ,General Medicine ,medicine.disease ,G-CSF-producing Tumor ,Granulocyte colony-stimulating factor ,medicine.anatomical_structure ,Hepatocellular carcinoma ,Carcinoma, Hepatocellular, Immunohistochemistry ,Receptors, Granulocyte Colony-Stimulating Factor ,Immunohistochemistry ,Bone marrow ,medicine.symptom - Abstract
Granulocyte-colony stimulating factor (G-CSF) is a naturally occurring glycoprotein that stimulates the proliferation and maturation of precursor cells in the bone marrow into fully differentiated neutrophils. Several reports of G-CSF-producing malignant tumors have been published, but scarcely any in the hepatobiliary system, such as in hepatocellular carcinoma (HCC). Here, we encountered a 69-yr-old man with a hepatic tumor who had received right hepatic resection. He showed leukocytosis of 25,450/mL along with elevated serum G-CSF. Histological examination of surgical samples demonstrated immunohistochemical staining for G-CSF, but not for G-CSF receptor. The patient survived without recurrence for four years, but ultimately passed away with multiple bone metastases. In light of the above, clinicians may consider G-CSF-producing HCC when encountering patients with leukocytosis and a hepatic tumor. More cases are needed to clarify the clinical picture of G-CSF-producing HCC., http://jkms.org/ | http://jkms.org/, Article, JOURNAL OF KOREAN MEDICAL SCIENCE. 25(3):476-480 (2010)
- Published
- 2010